Group penalized logistic regression differentiates between benign and malignant ovarian tumors

被引:0
|
作者
Xuemei Hu
Ying Xie
Yanlin Yang
Huifeng Jiang
机构
[1] Chongqing Technology and Business University,School of Mathematics and Statistics
[2] Chongqing Technology and Business University,Chongqing Key Laboratory of Social Economy and Applied Statistics
[3] Chongqing Vocational College of Science and Technology,General National Defense Education College
[4] Chongqing University of Eduaction,School of Economics and Business Administration
[5] Chongqing Technology and Business University,Research Center for Economy of Upper Reaches of the Yangtse River
来源
Soft Computing | 2023年 / 27卷
关键词
Ovarian cancer; GCD algorithm; GLASSO/GSCAD/GMCP penalty; Machine learning methods; Deep learning methods;
D O I
暂无
中图分类号
学科分类号
摘要
Ovarian cancer is one of the most common types of cancer in women. Correct differentiation between benign and malignant ovarian tumors is of immense importance in medical fields. In this paper, we introduce group penalized logistic regressions to enhance diagnosis accuracy. Firstly, we divide 349 ovarian cancer patients into two sets: one for learning model parameters, and the other for assessing prediction performance, and select 46 variables from 49 traits as the predictor vector to construct GLASSO/GSCAD/GMCP penalized logistic regressions with 11 groups. Secondly, we develop group coordinate descent (GCD) algorithm and its specific pseudo code to simultaneously complete group selection and group estimation, introduce the tenfold cross validation (CV) procedure to select the relatively optimal tuning parameter, and apply the testing set and Youden index to obtain class probability estimator and class index information. Finally, we compute the accuracy, precision, specificity, sensitivity, F1-score and the area under ROC curve (AUC) to assess the prediction performance to the proposed group penalized methods, and found that GLASSO/GSCAD/GMCP penalized logistic regressions outperform three machine learning methods (ANN, artificial neural network; SVM, support vector machine; XGBoost, eXtreme gradient boosting) and three deep learning methods (CNN, convolutional neural network; DNN, deep neural network; RNN, recurrent neural network) in terms of accuracy, F1-score and AUC.
引用
收藏
页码:18565 / 18584
页数:19
相关论文
共 50 条
  • [1] Group penalized logistic regression differentiates between benign and malignant ovarian tumors
    Hu, Xuemei
    Xie, Ying
    Yang, Yanlin
    Jiang, Huifeng
    SOFT COMPUTING, 2023, 27 (24) : 18565 - 18584
  • [2] Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: A multicenter study by the International Ovarian Tumor Analysis Group
    Timmerman, D
    Testa, AC
    Bourne, T
    Ferrazzi, E
    Ameye, L
    Konstantinovic, ML
    Van Calster, B
    Collins, WP
    Vergote, I
    Van Huffel, S
    Valentin, L
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) : 8794 - 8801
  • [3] Cytogenetic findings in phyllodes tumors of the breast: Karyotypic complexity differentiates between malignant and benign tumors
    Dietrich, CU
    Pandis, N
    Rizou, H
    Petersson, C
    Bardi, G
    Qvist, H
    Apostolikas, N
    Bohler, PJ
    Andersen, JA
    Idvall, I
    Mitelman, F
    Heim, S
    HUMAN PATHOLOGY, 1997, 28 (12) : 1379 - 1382
  • [4] A biomarker panel for distinguishing between malignant and benign ovarian tumors
    Ueland, F.
    Zhang, Z.
    Crutcher, G.
    Fung, E.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S98 - S99
  • [5] BORDERLINE OVARIAN TUMORS - ARE THEY BENIGN OR MALIGNANT?
    Lazarou, Anastasia
    Fotopoulou, Christina
    Coumbos, Alexandra
    Sehouli, Jalid
    Vasiljeva, Jekaterina
    Braicu, Ioana
    Burger, Heinz
    Kuehn, Wolfgang
    ANTICANCER RESEARCH, 2014, 34 (10) : 6257 - 6257
  • [6] IOTA Simple Rules in Differentiating between Benign and Malignant Ovarian Tumors
    Tantipalakorn, Charuwan
    Wanapirak, Chanane
    Khunamornpong, Surapan
    Sukpan, Kornkanok
    Tongsong, Theera
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (13) : 5123 - 5126
  • [7] Serological and immunohistochemical biomarkers for discrimination between benign and malignant ovarian tumors
    Dijmarescu, Anda Lorena
    Gheorman, Veronica
    Manolea, Maria Magdalena
    Vrabie, Sidonia Catalina
    Sandulescu, Maria Sidonia
    Silosi, Cristian Adrian
    Silosi, Isabela
    Radu, Mirela
    Popescu-Driga, Mircea Vasile
    Novac, Marius Bogdan
    Padureanu, Vlad
    Istrate-Ofiteru, Anca-Maria
    Boldeanu, Lidia
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2019, 60 (04): : 1163 - 1174
  • [9] Microvessel quantification in benign and malignant ovarian tumors
    Amis, S. J.
    Coulter-Smith, S. D.
    Crow, J. C.
    Maclean, A. B.
    Perrett, C. W.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (01) : 58 - 65
  • [10] Differentiation of benign and malignant breast tumors by logistic regression and a classification tree using Doppler flow signals
    Sauerbrei, W
    Madjar, H
    Prompeler, HJ
    METHODS OF INFORMATION IN MEDICINE, 1998, 37 (03) : 226 - 234